These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4889058)

  • 1. Carphenazine in the treatment of schizophrenic psychoses. Controlled clinical trial.
    Vinar O; Formánková M; Taussigová D; Růzicka S
    Act Nerv Super (Praha); 1967 Nov; 9(4):353-5. PubMed ID: 4889058
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug therapy of thought disorder in chronic paranoid schizophrenia: a longitudinal study.
    Wilson IC; Paulson GW; Sandifer MG
    Dis Nerv Syst; 1968 Aug; 29(8):550-1. PubMed ID: 4877898
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of carphenazine in hospitalized schizophrenic women.
    Cowley LM
    Dis Nerv Syst; 1967 Feb; 28(2):126-30. PubMed ID: 6021593
    [No Abstract]   [Full Text] [Related]  

  • 4. Piperacetazine in ambulatory chronic schizophrenic patients.
    Rada RT; Donlon PT
    Curr Ther Res Clin Exp; 1974 Feb; 16(2):124-9. PubMed ID: 4156665
    [No Abstract]   [Full Text] [Related]  

  • 5. [Pilot study on oxaflumazine, a new piperazinated phenothiazine].
    Villeneuve A; Dogan K; Lachance R; Drolet A
    Int J Clin Pharmacol; 1972 Aug; 6(3):246-55. PubMed ID: 4405378
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled study of placebo, chlordiazepoxide and chlorpromazine with thirty male schizophrenic patients.
    Hekimian LJ; Friedhoff AJ
    Dis Nerv Syst; 1967 Oct; 28(10):675-8. PubMed ID: 4860896
    [No Abstract]   [Full Text] [Related]  

  • 7. Oxypertine in schizophrenic psychoses. Controlled clinical trial in two psychiatric hospitals.
    Vinar O; Hamouz V; Bastecký J
    Act Nerv Super (Praha); 1968 Oct; 10(3):315-7. PubMed ID: 4883240
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluspirilene in the treatment of chronic schizophrenic outpatients.
    St-Laurent J; Carle R; Domingue D
    Curr Ther Res Clin Exp; 1972 Sep; 14(9):599-608. PubMed ID: 4628682
    [No Abstract]   [Full Text] [Related]  

  • 9. Predictors of therapeutic responsivity to thiothixene in schizophrenics.
    Sterlin C; Oliveros R; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jul; 1(5):394-6. PubMed ID: 4882603
    [No Abstract]   [Full Text] [Related]  

  • 10. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of dosage ranges of carphenazine and trifluoperazine in elderly chronic schizophrenics.
    Bora G
    Dis Nerv Syst; 1968 Oct; 29(10):695-7. PubMed ID: 4887393
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies with new drugs in the treatment of convulsive disorders.
    Lehmann HE; Ban TA
    Int Z Klin Pharmakol Ther Toxikol; 1968 Jan; 1(3):230-4. PubMed ID: 4387044
    [No Abstract]   [Full Text] [Related]  

  • 13. A double-blind comparison of the therapeutic efficacy of mesoridazine versus chlorpromazine.
    Freeman H; Oktem MR; Oktem N
    Curr Ther Res Clin Exp; 1969 May; 11(5):263-70. PubMed ID: 4977397
    [No Abstract]   [Full Text] [Related]  

  • 14. Octoclothepin in psychoses. A controlled clinical trial.
    Vinar O; Ledererová E; Taussigová D
    Act Nerv Super (Praha); 1968 Oct; 10(3):336-9. PubMed ID: 4883241
    [No Abstract]   [Full Text] [Related]  

  • 15. Indications for high dose chlorpromazine therapy in chronic schizophrenia.
    Prien RF; Levine J; Cole JO
    Dis Nerv Syst; 1970 Nov; 31(11):739-45. PubMed ID: 4923151
    [No Abstract]   [Full Text] [Related]  

  • 16. Prevalence and relationship to delusions and hallucinations of anxiety disorders in schizophrenia.
    Tibbo P; Swainson J; Chue P; LeMelledo JM
    Depress Anxiety; 2003; 17(2):65-72. PubMed ID: 12621594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical efficacy of leponex according to the findings of an international study].
    Panteleeva GN; Tsutsul'kovskaia MIa; Beliaev BS; Cheshkova E; Pavlovskiĭ P
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(3):393-401. PubMed ID: 6144219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loxapine: a double-blind comparison with chlorpromazine in acute schizophrenic patients.
    Steinbook RM; Goldstein BJ; Brauzer B; Moreno SS; Jacobson AF
    Curr Ther Res Clin Exp; 1973 Jan; 15(1):1-7. PubMed ID: 4631378
    [No Abstract]   [Full Text] [Related]  

  • 19. A controlled clinical trial of trifluperidol on a group of chronic schizophrenic patients.
    Menon MS; Ramachandran V
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):17-21. PubMed ID: 4621559
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical evaluation of clopenthixol.
    Yaryura-Tobias JA; Wolpert A; White L; Agola P; Merlis S
    Curr Ther Res Clin Exp; 1970 May; 12(5):271-9. PubMed ID: 4986242
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.